Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 185

1.

Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009-2015.

Leung J, Dollard SC, Grosse SD, Chung W, Do T, Patel M, Lanzieri TM.

Clin Ther. 2018 Mar;40(3):430-439.e1. doi: 10.1016/j.clinthera.2018.01.006. Epub 2018 Feb 4.

2.

Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.

Grosse SD, Peterson C, Abouk R, Glidewell J, Oster ME.

Int J Neonatal Screen. 2017;3(4):34. doi: 10.3390/ijns3040034. Epub 2017 Dec 14.

3.

Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.

Carias C, Chesson HW, Grosse SD, Li R, Meltzer MI, Miller GF, Murphy LB, Nurmagambetov TA, Pike JJ, Whitham HK.

Am J Prev Med. 2018 Apr;54(4):600-602. doi: 10.1016/j.amepre.2017.11.013. Epub 2018 Jan 12. No abstract available.

PMID:
29338958
4.

Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths.

Abouk R, Grosse SD, Ailes EC, Oster ME.

JAMA. 2017 Dec 5;318(21):2111-2118. doi: 10.1001/jama.2017.17627.

PMID:
29209720
5.

How Economic Findings Can Inform Prevention Research in Cardiovascular Disease.

Grosse SD.

Am J Prev Med. 2017 Dec;53(6S2):S118-S120. doi: 10.1016/j.amepre.2017.08.013. No abstract available.

6.

Conducting Research on the Economics of Hypertension to Improve Cardiovascular Health.

Wang G, Grosse SD, Schooley MW.

Am J Prev Med. 2017 Dec;53(6S2):S115-S117. doi: 10.1016/j.amepre.2017.08.005. No abstract available.

7.

In Reference to: "Cost and Utility of Thrombophilia Testing".

Berse B, Lynch JA, Bowen S, Grosse SD.

J Hosp Med. 2017 Sep;12(9):783. doi: 10.12788/jhm.2818. No abstract available.

PMID:
29056884
8.

Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.

Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.

Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.

PMID:
28933789
9.

Employer-Sponsored Plan Expenditures for Infants Born Preterm.

Grosse SD, Waitzman NJ, Yang N, Abe K, Barfield WD.

Pediatrics. 2017 Oct;140(4). pii: e20171078. doi: 10.1542/peds.2017-1078.

PMID:
28933347
10.

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.

Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.

MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.

PMID:
28880857
11.

CDC Grand Rounds: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease.

Grosse SD, Riehle-Colarusso T, Gaffney M, Mason CA, Shapira SK, Sontag MK, Braun KVN, Iskander J.

MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):888-890. doi: 10.15585/mmwr.mm6633a4.

12.

Prophylaxis use among males with haemophilia B in the United States.

Ullman M, Zhang QC, Grosse SD, Recht M, Soucie JM; Hemophilia Treatment Center Network Investigators.

Haemophilia. 2017 Nov;23(6):910-917. doi: 10.1111/hae.13317. Epub 2017 Aug 6.

PMID:
28780772
13.

Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.

Grosse SD, Gurrin LC, Bertalli NA, Allen KJ.

Genet Med. 2018 Apr;20(4):383-389. doi: 10.1038/gim.2017.121. Epub 2017 Aug 3. Review.

PMID:
28771247
14.

Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?

Lain S, Trumpff C, Grosse SD, Olivieri A, Van Vliet G.

Eur J Endocrinol. 2017 Nov;177(5):D1-D12. doi: 10.1530/EJE-17-0107. Epub 2017 Jul 10. Review.

15.

The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.

Soucie JM, Grosse SD, Siddiqi AE, Byams V, Thierry J, Zack MM, Shapiro A, Duncan N; Hemophilia Treatment Centers Network.

Haemophilia. 2017 Jul;23(4):e287-e293. doi: 10.1111/hae.13275. Epub 2017 Jun 2.

PMID:
28574229
16.

Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States.

Nyarko KA, Grosse SD, Danielson ML, Holbrook JR, Visser SN, Shapira SK.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):731-734. doi: 10.1089/cap.2016.0196. Epub 2017 Mar 22.

PMID:
28328236
17.

Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection.

Lanzieri TM, Chung W, Flores M, Blum P, Caviness AC, Bialek SR, Grosse SD, Miller JA, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Pediatrics. 2017 Mar;139(3). pii: e20162610. doi: 10.1542/peds.2016-2610. Epub 2017 Feb 16.

18.

Accounting for differences in healthcare utilization and expenditures among US males with haemophilia by type of health insurance.

Guh S, Grosse SD, Ullman M, Soucie JM.

Haemophilia. 2017 Mar;23(2):e147-e151. doi: 10.1111/hae.13161. Epub 2017 Feb 2. No abstract available.

19.

Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.

Grosse SD, Lam WKK, Wiggins LD, Kemper AR.

Genet Med. 2017 Sep;19(9):975-982. doi: 10.1038/gim.2016.223. Epub 2017 Jan 26.

PMID:
28125077
20.

Screening for Congenital Cytomegalovirus After Newborn Hearing Screening: What Comes Next?

Grosse SD, Dollard SC, Kimberlin DW.

Pediatrics. 2017 Feb;139(2). pii: e20163837. doi: 10.1542/peds.2016-3837. No abstract available.

Supplemental Content

Loading ...
Support Center